News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD) Execs Bag Pay Hikes, $8 Million In Bonuses



1/31/2014 7:58:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

While facing cries that its cutting-edge hepatitis and HIV drugs are overpriced, Gilead Sciences Inc. awarded nearly $8 million in bonuses to its five top officers. John Martin, chairman and CEO of the Foster City-based company (NASDAQ: GILD) and the focus of much of the criticism, landed a bonus for 2013 of $3.5 million, the company said Wednesday in a Securities and Exchange Commission filing. Additionally, President and COO John Milligan scored a $1.5 million bonus for last year, Chief Scientific Officer Norbert Bischofberger won a nearly $1.1 million bonus, outgoing commercial operations chief Kevin Young got $978,000 and CFO Robin Washington received $787,500.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES